Peroxisome proliferator-activated receptor ligands in atherosclerosis.

about

Immune mechanisms in thyroid eye disease.

P2860

Q37254482-E5BF8DFD-88AC-4772-B22C-94E49567F88D

P2860

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

Item

http://www.wikidata.org/entity/Q35925566

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

@ast

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

@en

type

Item

label

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

@ast

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

@en

prefLabel

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

@ast

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

@en

P1476

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

@en

P2093

Brian G Choi

http://www.w3.org/2001/XMLSchema#string

Juan F Viles-Gonzalez

http://www.w3.org/2001/XMLSchema#string

Juan J Badimon

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

Inflammation in atherosclerosis

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages.

Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.

Rosiglitazone monotherapy is effective in patients with type 2 diabetes.

P304

1393-1403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.13.11.1393

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Valentín Fuster Carulla

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15500388

http://www.w3.org/2001/XMLSchema#string

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

about

P2860

P2860

Peroxisome proliferator-activated receptor ligands in atherosclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698